LINEAGE CELL THERAPEUTICS INC has a total of 20 patent applications. It increased the IP activity by 700.0%. Its first patent ever was published in 2010. It filed its patents most often in Australia, United States and EPO (European Patent Office). Its main competitors in its focus markets pharmaceuticals, biotechnology and medical technology are QBI ENTPR LTD, CALIMMUNE INC and GENETIC THERAPY INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | Australia | 7 | |
#2 | United States | 4 | |
#3 | EPO (European Patent Office) | 3 | |
#4 | Brazil | 1 | |
#5 | Canada | 1 | |
#6 | China | 1 | |
#7 | Israel | 1 | |
#8 | Republic of Korea | 1 | |
#9 | WIPO (World Intellectual Property Organization) | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Medical technology |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Microorganisms | |
#3 | Medical preparations | |
#4 | Measuring microorganism processes | |
#5 | Peptides | |
#6 | Implantable devices | |
#7 | Object sterilising |
# | Name | Total Patents |
---|---|---|
#1 | Chapman Karen B | 8 |
#2 | West Michael D | 7 |
#3 | Binette Francois | 5 |
#4 | Cuzzani Oscar | 5 |
#5 | Gurevich Maria | 4 |
#6 | Netzer Nir | 4 |
#7 | Skaliter Rami | 4 |
#8 | Cohen Ohad | 4 |
#9 | Kayser Stephanie | 4 |
#10 | Hogge Gary | 4 |
Publication | Filing date | Title |
---|---|---|
AU2019342741A1 | Methods for differentiating pluripotent stem cells in dynamic suspension culture | |
CN110913874A | Method for measuring the efficacy of a retinal disease therapy | |
AU2011258249A1 | Improved methods of screening embryonic progenitor cell lines | |
AU2011218041A1 | Methods for telomere length and genomic DNA quality control analysis in pluripotent stem cells |